Plexus/$PLXS
1D1W1MYTD1Y5YMAX
Capital at risk
About Plexus
Plexus Corp designs, manufactures, and services complex products in demanding regulatory environments, supporting life-saving medical devices, mission-critical aerospace and defense products, industrial automation systems, and semiconductor capital equipment. Its integrated lifecycle solutions span design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services for market and disruptive companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The Company operates through three reportable segments: AMER, APAC, and EMEA, with the majority of revenue from the APAC segment.
- Ticker
- $PLXS
- Sector
- Digital Hardware
- Primary listing
- NASDAQ
- Employees
- 20,000
- Headquarters
- Neenah, United States
- Website
- www.plexus.com
Plexus Metrics
BasicAdvanced
$7.3B
40.33
$6.77
0.89
-
Price and volume
Market cap
$7.3B
Beta
0.89
52-week high
$307.06
52-week low
$132.03
Average daily volume
219K
Financial strength
Current ratio
1.488
Quick ratio
0.67
Long term debt to equity
0.076
Total debt to equity
0.201
Interest coverage (TTM)
17.99%
Profitability
EBITDA (TTM)
307.106
Gross margin (TTM)
10.04%
Net profit margin (TTM)
4.03%
Operating margin (TTM)
5.01%
Effective tax rate (TTM)
13.77%
Revenue per employee (TTM)
$230,000
Management effectiveness
Return on assets (TTM)
4.26%
Return on equity (TTM)
12.58%
Valuation
Price to earnings (TTM)
40.326
Price to revenue (TTM)
1.591
Price to book
4.77
Price to tangible book (TTM)
4.77
Price to free cash flow (TTM)
118.237
Free cash flow yield (TTM)
0.85%
Free cash flow per share (TTM)
2.31
Growth
Revenue change (TTM)
14.20%
Earnings per share change (TTM)
15.37%
3-year revenue growth (CAGR)
2.17%
10-year revenue growth (CAGR)
5.98%
3-year earnings per share growth (CAGR)
8.62%
10-year earnings per share growth (CAGR)
11.07%
What the Analysts think about Plexus
Analyst ratings (Buy, Hold, Sell) for Plexus stock.
Analyst projections of the future price of Plexus stock.
Bulls say / Bears say
Plexus posted record Q3 FY26 revenue of $1.305 billion, up 28% year on year, and raised its FY26 growth outlook to above 20%. Management sees FY27 growth exceeding its 9%–12% target. (Plexus Corp.)
New programme wins offer a sizeable growth runway: Q3 manufacturing wins represented $255 million of annualised revenue at full ramp, while qualified opportunities reached a record $4.5 billion. (Plexus Corp.)
Profitability is improving alongside growth: Q3 non-GAAP operating margin was 6.3%, up 30 basis points year on year. Plexus expects to exceed 6% for FY26 and sees further margin expansion in FY27. (Plexus Corp.)
Fast programme ramps are consuming cash: Plexus expects to use free cash flow in FY26, reversing its earlier forecast of $50–$75 million in generation, and anticipates a return to meaningful generation only in early FY27. (MetaTrader)
Reported earnings lagged sales growth: despite a 28% year-on-year revenue increase, Q3 GAAP diluted EPS fell to $1.58 from $1.64 and operating margin was 4.7%. Higher stock-based compensation and taxes weighed on results. (Last10K)
Customer concentration leaves Plexus exposed if a major account cuts or delays orders: its ten largest customers generated 55% of Q3 revenue, seven percentage points more than a year earlier. (Plexus Corp.)
Data summarised monthly by Lightyear AI. Last updated on 3 Oct 2026.
Plexus Financial Performance
Revenues and expenses
Plexus Earnings Performance
Company profitability
Upcoming events
No upcoming events
Plexus News
AllArticlesVideos
Funds containing Plexus
AllUSDGBPEUR
Fund name | Fund size | $PLXS weighting |
|---|---|---|
iShares S&P SmallCap 600$IDP6 | $3.2B | 0.42% |
iShares S&P Small Cap 600£ISP6 | £2.4B | 0.42% |
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.24% |
SPDR Russell 2000 US Small Cap£R2SC | £4.1B | 0.24% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | €2.8B | 0.21% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.